Annual Drug Patent Expirations for MEKINIST
Mekinist is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug.
This drug has one hundred and thirty-three patent family members in forty-five countries.
The generic ingredient in MEKINIST is trametinib dimethyl sulfoxide. One supplier is listed for this compound. Additional details are available on the trametinib dimethyl sulfoxide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
